High-throughput HPV testing: NHSCSP approval secured

In January 2016, the NHS National Screening Committee (NSC) recommended that the Cervical Screening Programme should replace cytological screening with the molecular HPV test as the primary form of screening. It is expected that this molecular HPV screening test will be rolled-out nationally by December 2019. This is a positive move to a more accurate test, which could prevent around 600 cancers a year.

This story is Premium Content and is only available to registered users. If you don't already have an account, please register with us completely free of charge.
 

Other news

Upcoming Events

British Society for Haematology 59th Annual Scientific Meeting

SEC Glasgow
1-3 April 2019

Focus 2019

SEC Glasgow
1-3 May 2019

Respiratory Microbiology - A Day of Inspiration

Royal Air Force Museum, Hendon
16 May 2019

Clinical and Laboratory Haemostasis 2019

The Atrium Conference Centre, Sheffield Hallam University
5-6 June 2019

The Oxford Haematology in Obstetrics Postgraduate Course

St Edmund Hall, Queen's Lane, Oxford OX1 4AR
9-11 September 2019

Latest Issue

Pathology In Practice

Pathology In Practice

Feb 2019

Early disease detection: a collaborative approach

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.